PAC-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PAC-1, covering 2023-11-22 to 2023-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma [Phase 1, Phase 2]